The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of a mutant KRAS-targeted long peptide vaccine combined with ipilimumab/nivolumab in resected pancreatic cancer and MMR-proficient metastatic colorectal cancer.
 
Saurav Daniel Haldar
No Relationships to Disclose
 
Thatcher Ross Heumann
No Relationships to Disclose
 
Maureen Berg
No Relationships to Disclose
 
Anna Ferguson
No Relationships to Disclose
 
Su Jin Lim
No Relationships to Disclose
 
Hao Wang
No Relationships to Disclose
 
Julie Nauroth
No Relationships to Disclose
 
Dan Laheru
No Relationships to Disclose
 
Elizabeth M. Jaffee
Stock and Other Ownership Interests - ABMETA Therapeutics
Consulting or Advisory Role - Achilles Therapeutics; Adaptive Biotechnologies; BlueDot; Candel Therapeutics; Carta; Dragonfly Therapeutics; Genocea Biosciences; Medically Home; NextCure
Research Funding - Bristol-Myers Squibb; Roche
Patents, Royalties, Other Intellectual Property - I developed GVAX which is being tested in the clinics. It was licensed to Adoro Biotech. IF it becomes commercial I will have the potential to receive royalties. Also, I have received milestone payments yearly.
 
Nilofer Saba Azad
Consulting or Advisory Role - AstraZeneca; Helsinn Therapeutics/QED Therapeutics; Incyte; Merck; Mirati Therapeutics; QED Therapeutics
Research Funding - Agios (Inst); Array BioPharma (Inst); Astex Pharmaceuticals (Inst); AtlasMedx (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Debiopharm Group (Inst); EMD Serono; Genentech (Inst); Incyte (Inst); Intensity Therapeutics (Inst); Loxo/Lilly (Inst); Merck (Inst); Syndax (Inst)
 
Neeha Zaidi
Consulting or Advisory Role - HalioDx; Ipsen